Is Adagene Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Adagene Inc (ADAG) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Adagene Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Adagene Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Adagene Inc?

Muslim investors may consider investing in Adagene Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Adagene Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Adagene Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Adagene Inc updated?

The Shariah compliance status of Adagene Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Adagene Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Adagene Inc?

You can check the latest Shariah compliance status of Adagene Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ADAG Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 29, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Adagene Inc (ADAG)

Based on 13 analysts giving stock ratings to Adagene Inc in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Adagene Inc. Stock Analysis ADAG

United States Health Care Micro Cap Report: 2025 Annual

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. The firm is principally engaged in the research, development and production of monoclonal antibody drugs for cancers. The Company’s main products include: ADG106 is being developed for the treatment of advanced solid tumors and non-Hodgkin's lymphoma, or NHL. ADG126 is designed to address the toxicity and efficacy issues related to the MOA of existing approved CTLA-4 immuno-oncology therapies and to expand the potential of CTLA-4 as a target for the treatment of cancer. ADG116 is designed to target a unique conserved epitope of CTLA-4. And ADG104, a monospecific antibody that targets PD-L1 and is in Phase Ib and Phase II clinical trials concurrently in China.

Key Statistics of Adagene Inc (ADAG)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$3.45$3.65

Today's Open

$3.60

Volume

23.47K

P/E Ratio (TTM)

52 Week Range

$1.30$4.75

Market Cap

173.43M

Avg. Volume

159.14K

Dividend Yield

Financial Metrics & Statements of Adagene Inc (ADAG)

FAQ's for Adagene Inc (ADAG)

According to Musaffa’s Shariah screening methodology, Adagene Inc (ADAG) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.